
Region:Libyan Arab Jamahiriya
Author(s):Aishwarya Kochhar, Chitra Vasu, Ritika Garg
Product Code:KR1166
July 2022
42
By Product: Central Lab Devices have dominated the market in terms of installations in 2021, due to the majority of tests being conducted in the hospitals.
By Sales Model and Workload: Consumable Model contributed the majority percentage share in terms of installations in 2021. BGA market has a low percentage for the outright sale model and high installation for Medium to High Sample Size Analyzers with government and private hospitals, which are offered by the benchtop devices such as CCA-TS2 series by Opti Medical.
By Type of End Users: Hospitals have a higher installed base over independent labs, specifically Government hospitals with >80% of the market captured in Libya since BGA has a higher testing demand for overnight admitted patients and such devices are required for patients in ICUs and NICUs.
POC Immunoassay Analyzer market is growing at a steady pace in Libya with major devices imported from European countries. It is a concentrated market with Boditech Med leading the market in Libya with high-quality devices, which are rich in features. There are other Chinese and Korean companies operating in the market. iChroma from Boditech Med is a popular choice for most end users.
POC IAA Market is expected to grow at a CAGR of 13.7% owing to technological advancements and standardizing protocols. Devices are advancing continuously in terms of size and operating parameters and are expected to see low maintenance and high-quality multi-parametric device in the future.
By Product: POC Benchtop has slightly dominated the market in terms of installations in 2021. However, POC Handheld IAA is also becoming a popular choice.
By Sales Model: IAA market has a high percentage for the outright sale model. Since the device costs are low for POC-IAA in Libya hence, they are majorly sold through the outright model with variations in the no. of tests and types of tests conducted on each machine.
By Type of End users: Majority of the POC Immunoassay is sold via Tender based process fairly addressing both hospitals and clinics & independent labs as the end-users, with equivalent load in terms of tests in both private and public hospitals in Libya.
Blood Gas Analyzer
POC Immunoassay Analyzer
Companies Covered:
Equipment Manufacturers
1.1. Executive Summary (Industry Overview, Challenges & Trends along with competition and way forward)
1.2. Executive Summary based on the total installed base for BGA and IAA
2.1. Country Overview by understanding the economical position along with the foreign trade scenario
2.2. Population Analysis, 2021
2.3. Healthcare in Libya
2.4. Challenges in the Healthcare System
2.5. Prevalence of Diseases; Cardiovascular diseases, Neonatal Diseases, and Immunological Disease
3.1 Business Cycle and Genesis of both devices i.e., BGA and IAA
3.2 Ecosystem
3.3 Value Chain Analysis
3.4 Competitive Landscape of BGA and IAA of the diagnostic equipment
3.5 Cross comparison of Major Brands (such as Opti Medical, Boditech Med, Radiometer, and more) on the basis of qualitative parameters such as Device names, Best Seller & Recent Developments
3.6 Cross comparison of Major Brands (such as Opti Medical, Boditech Med, Radiometer, and more) on the basis of installed units, distributor’s bestselling products, the price for the test
4.1. BG Analyzer Market Overview, 2021
4.2. Market Size on the total installed base, 2021
4.3. Market Segmentation (Basis Installed Base) such as Type of Device, End-User, and More, 2021
4.4. Market Share of the Major Brands in the BGA Analyzer Market
4.5. Future of the BGA Market and way forward, 2021-2026F
5.1. Current Market on the basis of total installations, market segmentation, current challenges, and drivers, 2021
5.2. Average Cost of POC IAA per test, 2021
5.3. Future Market on the basis of total installations, market segmentations, and Future Growth Drivers, 2021-2026F
6.1. Market Definitions, Market Sizing Approach and Entity Analysis, Primary Research Approach, Correlation Matrix, Regression Matrix, Research Limitations, and Future Conclusions
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.